The newly elected President of Medicines for Europe – Marc-Alexander Mahl – […]
READ MOREValue added medicines represent a major opportunity to improve patients’ […]
READ MOREA new study “Value Added Medicines: Time to Adjust the […]
Read moreBiosimilar medicines are transforming treatment by enabling better access to […]
Read moreOver 100 participants explored different ways and opportunities to ensure […]
Read moreA special satellite symposium was organized on “Value added medicines […]
Read moreKey authorities, eminent lawyers and industry leaders discussed today in […]
Read moreToday, the European Parliament voted on the report on ‘Options […]
Read moreEurope is the cradle of the manufacturing industry and has […]
Read moreThe European associations representing manufacturers of medicinal products, parallel distributors, […]
Read more